Angitia Biopharmaceuticals Announces 120 Million Series C Financing
| DVLCX Fund | USD 22.51 0.12 0.53% |
Slightly above 61% of Dreyfus Opportunistic's investor base is looking to short. The analysis of overall sentiment of trading Dreyfus Opportunistic Midcap mutual fund suggests that many investors are alarmed at this time. Dreyfus Opportunistic's investing sentiment can be driven by a variety of factors including economic data, Dreyfus Opportunistic's earnings reports, geopolitical events, and overall market trends.
Dreyfus |
- Financing led by Bain Capital Life Sciences with significant participation from existing and new investors - Proceeds will support the development of AGA2118, AGA2115, AGA111 and other pipeline assets for the treatment of serious musculoskeletal diseases - Norbert Riedel, Ph.D., will join the Board of Directors WOODLAND HILLS, Calif., Dec. 11, 2024 -- Angitia Biopharmaceuticals , a clinical-stage biotechnology company focused on the discovery and de
Read at finance.yahoo.com
 |
Dreyfus Opportunistic Fundamental Analysis
We analyze Dreyfus Opportunistic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dreyfus Opportunistic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dreyfus Opportunistic based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Dreyfus Opportunistic is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Dreyfus Opportunistic Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dreyfus Opportunistic mutual fund to make a market-neutral strategy. Peer analysis of Dreyfus Opportunistic could also be used in its relative valuation, which is a method of valuing Dreyfus Opportunistic by comparing valuation metrics with similar companies.
Peers
Dreyfus Opportunistic Related Equities
| DHGCX | Dreyfus/standish | 0.16 | ||||
| DIECX | Dreyfus International | 0.11 | ||||
| DHYAX | Dreyfus High | 0.09 | ||||
| DHGAX | Dreyfus/standish | 0.10 | ||||
| DIBAX | Dreyfus International | 0.17 | ||||
| DHYCX | Dreyfus High | 0.18 | ||||
| DIBCX | Dreyfus International | 0.27 | ||||
| DIEAX | Dreyfus International | 0.41 | ||||
| DZNJX | Dreyfus New | 0.51 | ||||
| DHMBX | Dreyfus High | 0.64 |
Other Information on Investing in Dreyfus Mutual Fund
Dreyfus Opportunistic financial ratios help investors to determine whether Dreyfus Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dreyfus with respect to the benefits of owning Dreyfus Opportunistic security.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |